Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-25 @ 2:04 AM
NCT ID:
NCT05682560
Eligibility Criteria:
Inclusion Criteria:
* 1\. Male or female aged ≥ 18
* 2\. With post-COVID syndrome
* 3\. Has had a recent (within 7 days) negative SARS-CoV-2 test (an approved PCR or antigen test)
* 4\. Able to provide signed informed consent (by the subject or his/her legally authorized representative)
* 5\. Is willing and able to participate in all aspects of the study, including completion of subjective evaluations, attendance at scheduled clinic visits, and compliance with all protocol requirements as evidenced by providing a written informed consent
Exclusion Criteria:
* 1\. Neurological disorders prior to COVID-19 diagnosis
* 2\. With pre-existing terminal illness
* 3\. With known immune disease
* 4\. Is pregnant or breastfeeding
* 5\. Is currently participating in another investigational study or has been taking any other investigational product within the last 4 weeks before screening
* 6\. Has received any vaccination within 3 weeks prior to the first IP infusion
* 7\. Judged by the investigator to be not suitable for study participation
* 8\. Under the conditions that may increase risk of complications based on the medical judgment of the investigator and the parameters
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT05682560
Study Brief:
Protocol Section:
NCT05682560